An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy
Sean A. Yamada‐Hunter(Stanford University), Jennifer R. Cochran(Stanford University)
Cited by 27
Related Papers
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
|Nature Chemical Biology|2021|579
Delivery of CAR-T cells in a transient injectable stimulatory hydrogel niche improves treatment of solid tumors
|Science Advances|2022|236
Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro
|Nature Communications|2022|51
Lysosome Targeting Chimeras (LYTACs) That Engage a Liver-Specific Asialoglycoprotein Receptor for Targeted Protein Degradation
|ChemRxiv|2020|13
An engineered interleukin‐11 decoy cytokine inhibits receptor signaling and proliferation in lung adenocarcinoma
|Bioengineering & Translational Medicine|2023|5